Xavier Rosselló

Xavier Rosselló is a prominent cardiologist and researcher at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Spain, known for his work in understanding cardiovascular diseases and their treatment. He recently gained attention for his involvement in the REBOOT trial, which revealed that women treated with beta-blockers after a heart attack face a higher risk of adverse outcomes compared to their male counterparts, emphasizing the need for gender-specific approaches in cardiovascular treatment.